Edwards Acquires JenaValve And Endotronix; Aggregate Upfront Purchase Price ~$1.2B
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences has acquired JenaValve and Endotronix for an aggregate upfront purchase price of approximately $1.2 billion.
July 24, 2024 | 8:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Edwards Lifesciences has acquired JenaValve and Endotronix for an aggregate upfront purchase price of approximately $1.2 billion. This acquisition is likely to expand Edwards' product portfolio and market reach in the cardiovascular space.
The acquisition of JenaValve and Endotronix by Edwards Lifesciences is a significant move that is likely to enhance its product offerings and market position in the cardiovascular sector. This strategic acquisition is expected to have a positive impact on Edwards' stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100